TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bioplanum AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4
|
49
|
64 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-8
|
20
|
10 |
| EBITDA |
-7
|
20
|
10 |
| Total assets |
16
|
23
|
32 |
| Current assets |
14
|
21
|
30 |
| Current liabilities |
13
|
3
|
16 |
| Equity capital |
3
|
20
|
15 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
18.8%
|
87.0%
|
46.9% |
| Turnover per employee |
4
|
49
|
64 |
| Profit as a percentage of turnover |
-200%
|
40.8%
|
15.6% |
| Return on assets (ROA) |
-50.0%
|
87.0%
|
31.2% |
| Current ratio |
107.7%
|
700%
|
187.5% |
| Return on equity (ROE) |
-266.7%
|
100%
|
66.7% |
| Change turnover |
-43
|
-15
|
25 |
| Change turnover % |
-92%
|
-23%
|
64% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.